{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Weeki Wachee",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79803",
      "recalling_firm": "Premier Pharmacy Labs Inc",
      "address_1": "8265 Commercial Way",
      "address_2": "N/A",
      "postal_code": "34613-4511",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0702-2018",
      "product_description": "NEOstigmine Methylsulfate (1 mg/mL) 3mg per 3mL. 3mL Single Dose Syringe. Premier Pharmacy Labs. 8265 Commercial Way  Weeki Wachee, FL 34613 NDC 69623-234-14.",
      "product_quantity": "600 syringes",
      "reason_for_recall": "Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.",
      "recall_initiation_date": "20180411",
      "center_classification_date": "20180426",
      "termination_date": "20200915",
      "report_date": "20180502",
      "code_info": "Lot: NEO022218SVDS BUD: 8/21/2018"
    }
  ]
}